SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-300219
Filing Date
2022-12-07
Accepted
2022-12-07 17:07:33
Documents
13
Period of Report
2022-12-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d431885d8k.htm   iXBRL 8-K 29198
2 EX-3.1 d431885dex31.htm EX-3.1 172560
  Complete submission text file 0001193125-22-300219.txt   367746

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aadi-20221206.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20221206_lab.xml EX-101.LAB 19482
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20221206_pre.xml EX-101.PRE 12147
7 EXTRACTED XBRL INSTANCE DOCUMENT d431885d8k_htm.xml XML 3687
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 221450792
SIC: 2834 Pharmaceutical Preparations